Research location
New Hyde Park
New York, United States
Advertisement
Research activity in New Hyde Park
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 380 trials and 388 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in New Hyde Park
380 linked trials · page 2 of 8Simufilam 100 mg for Mild-to-Moderate Alzheimer's DiseaseNCT04994483 · 2021-11-03 · 1 site observation
COMPLETED
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)NCT04829604 · 2021-10-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Determination and Validation of a Multi-analyte Assay for Lung Cancer ScreeningNCT04968548 · 2021-09-17 · 1 site observation
COMPLETED
A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)NCT04813926 · 2021-07-16 · 1 site observation
COMPLETED
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)NCT04964934 · 2021-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Detection of Heart Conditions Using Artificial IntelligenceNCT04933890 · 2021-06-01 · 1 site observation
COMPLETED
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialNCT04320888 · 2021-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)NCT04609878 · 2020-12-15 · 1 site observation
COMPLETED
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNCT04284774 · 2020-10-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT04464564 · 2020-09-11 · 1 site observation
TERMINATED
Personalized Therapy Study - HFRS (TriageHF) Post Approval StudyNCT04489225 · 2020-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)NCT04195555 · 2020-07-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationNCT04456673 · 2020-07-06 · 1 site observation
COMPLETED
Gan & Lee Evaluation of New Biosimilar for Type 1 LisproNCT04254380 · 2019-12-04 · 1 site observation
WITHDRAWN
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesNCT04137900 · 2019-10-30 · 1 site observation
UNKNOWN
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic AsthmaNCT04046939 · 2019-08-15 · 1 site observation
COMPLETED
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)NCT03974022 · 2019-07-09 · 1 site observation
ACTIVE_NOT_RECRUITING
ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast CancerNCT03950570 · 2019-05-25 · 2 site observations
COMPLETED
PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.NCT03414762 · 2019-04-01 · 1 site observation
COMPLETED
Long Term Outcomes of Bariatric Patients Treated With Surgery or EndoscopyNCT03705416 · 2019-03-30 · 1 site observation
ACTIVE_NOT_RECRUITING
An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)NCT03712787 · 2019-03-22 · 1 site observation
TERMINATED
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With AsthmaNCT03847896 · 2019-03-20 · 1 site observation
COMPLETED
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationNCT03833154 · 2019-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With AsthmaNCT03769090 · 2018-12-13 · 1 site observation
COMPLETED
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)NCT03698994 · 2018-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Mylan Insulin Aspart StudyNCT03760068 · 2018-11-07 · 1 site observation
COMPLETED
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerNCT03732820 · 2018-10-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT03703297 · 2018-09-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)NCT03526250 · 2018-08-13 · 1 site observation
COMPLETED
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsNCT03595059 · 2018-07-13 · 1 site observation
COMPLETED
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)NCT03210714 · 2018-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)NCT03213652 · 2018-04-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung CancerNCT03382912 · 2018-03-22 · 1 site observation
TERMINATED
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)NCT03373045 · 2018-02-27 · 1 site observation
COMPLETED
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPDNCT03255057 · 2018-02-18 · 1 site observation
TERMINATED
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)NCT03213678 · 2017-11-28 · 1 site observation
COMPLETED
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)NCT03213665 · 2017-11-13 · 1 site observation
COMPLETED
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)NCT03305809 · 2017-11-09 · 1 site observation
COMPLETED
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)NCT03220035 · 2017-11-08 · 1 site observation
COMPLETED
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]NCT03265145 · 2017-09-20 · 1 site observation
COMPLETED
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)NCT03233204 · 2017-09-14 · 1 site observation
COMPLETED
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)NCT03213704 · 2017-08-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Personalized Therapy Study - Attain Stability Quad Post-Approval StudyNCT04024943 · 2017-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusNCT03240575 · 2017-08-14 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620 · 2017-07-31 · 1 site observation
ACTIVE_NOT_RECRUITING
ADAPT - A Patient Registry of the Real-world Use of Orenitram®NCT03045029 · 2017-07-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.NCT03170271 · 2017-07-07 · 1 site observation
COMPLETED
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerNCT03078751 · 2017-06-20 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFENCT02630316 · 2017-02-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.